Lyrica, seen here, is Pfizer’s best-selling drug after cholesterol pill Lipitor. Photographer: JB Reed/Bloomberg
Lyrica, seen here, is Pfizer’s best-selling drug after cholesterol pill Lipitor. Photographer: JB Reed/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=575892319&utmp=%2Fphoto%2F2012-06-21%2Fpfizer-s-lyrica-gains-u-s-approval-for-spinal-pain&utmhn=10.248.179.13&utmac=UA-11413116-12&utmhid=919005994)